U S Physical Therapy Inc
USPHNYSECIK 885978HealthcareFiscal year ends Dec 31
Reports and events: 520 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2817:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885978-26-000060 |
| 2026-09-2116:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-26-000057 |
| 2026-08-1416:17 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000052 |
| 2026-08-1216:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000048 |
| 2026-08-1016:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000045 |
| 2026-08-0716:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-031825 |
| 2026-08-0616:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000042 |
| 2026-07-0616:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000039 |
| 2026-05-1916:50 ET | 8-K | 5.07 Shareholder vote results | 0000885978-26-000027 |
| 2026-05-1117:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000024 |
| 2026-05-0816:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001140361-26-020025 |
| 2026-05-0616:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000019 |
| 2026-04-1606:24 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001140361-26-014952 |
| 2026-04-1516:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000885978-26-000017 |
| 2026-03-1316:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000885978-26-000014 |
| 2026-03-0916:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000011 |
| 2026-03-0316:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-26-000009 |
| 2026-02-2717:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-007170 |
| 2026-02-2608:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006882 |
| 2026-02-0416:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000006 |
| 2026-01-0716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-26-000003 |
| 2025-11-1816:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000058 |
| 2025-11-1216:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000056 |
| 2025-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-041152 |
| 2025-11-0616:22 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000053 |
| 2025-08-1216:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000046 |
| 2025-08-1116:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000044 |
| 2025-08-0808:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-029744 |
| 2025-08-0707:33 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000041 |
| 2025-08-0116:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000037 |
| 2025-07-0117:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000032 |
| 2025-05-2816:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000019 |
| 2025-05-2016:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000885978-25-000017 |
| 2025-05-1316:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000014 |
| 2025-05-1317:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000012 |
| 2025-05-0916:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001140361-25-018157 |
| 2025-05-0717:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000010 |
| 2025-04-3016:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000008 |
| 2025-04-1116:03 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0001140361-25-013467 |
| 2025-03-2806:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-010807 |
| 2025-03-0708:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-25-000006 |
| 2025-03-0316:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001140361-25-006750 |
| 2025-03-0314:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000004 |
| 2025-02-2717:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-25-000002 |
| 2024-12-0216:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000068 |
| 2024-11-1216:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000066 |
| 2024-11-0816:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000885978-24-000064 |
| 2024-11-0816:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-045836 |
| 2024-11-0616:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000885978-24-000062 |
| 2024-11-0116:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events | 0000885978-24-000059 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:40 ET. Listed shows no prices and gives no investment advice.